Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

Author's Avatar
Apr 25, 2018
Article's Main Image

-Company Eligible to Receive Up to $43.75 Million in Milestones for Each IVR Candidate, Plus Royalties on Future Sales-

PR Newswire